Narendra Nirmal Jana

Email: narenjana@narenjana.com

Email: narenj5@protonmail.com

December 3rd 2020 Asylum Interview:

Home Office Reference #: J1989785

Application ASC #: ASC/5271126

Back to Main Page

Lack of Legal/Police to Stop the Militated Persecution of me Anywhere

Lack of Legal/Police to Stop the Militated Persecution of me Anywhere

My Medical Documents Section

My Medical Documents Section

Medical Doctors Causing Harm (Full Documented Proof) in Clinical Settings to My Disablement in US Persecution

Medical Doctors Causing Harm (Full Documented Proof) in Clinical Settings to My Disablement in US Persecution

The Bigger Case (US Internet Malice and Social Isolation (From Same age and Opposite Sex) by Physical and Digital Methods)

The Bigger Case (US Internet Malice and Social Isolation (From Same age and Opposite Sex) by Physical and Digital Methods)

Medical Documents to Substantiate my Condition

Article About Deferiprone

Article About Deferiprone

Clinical Summaries Given in the Main Page

2019.04.17 Dr. Hugo Clinical Summary

2019.04.10 Dr. Amaya Clinical Summary

2019.05.22 Dr. Manjarrez Clinical Summary

Dr. Klaffke Clinical Summary 2019

Explaining History Behind Treating Physicians

(New 1st) It should be clarified in the following documents that the patient has full medical insurance (all benefits from insurance) in the US and has always had insurance but the stipulate is that only for the condition Multiple Sclerosis (not other conditions like diabetes) only a *US physician* is allowed to approve the payments for the medication by insurance. The US used it as a way to withhold treatment/medications. The medications cost more than 1500 USD per month.

In one instance when a physician abroad prescribed the medication and I paid for it without insurance, the US simply directed someone to steal the medication to keep me sick. The US is aggressive in withholding medications to cause harm.

2017 May Onwards Dr.Hugo

2019 April 10th Mexico City - Dr. Luis Amaya Summary

2019 April 22nd Tijuana - Dr. Francisco Manjarrez

2018 March 19th onwards Dr. Stefanie Klaffke

Emergency Room (ER) Documents (Because the US Wouldnt Treat the Condition in the US)

Mexico

ER Methylpredniolone IV Report September 2017 Mexico

(New 12th) Pictures-The Condition in Emergency Settings Abroad is Usually Severe due to the US being Aggressive in Medical Mistreatment

History Behind 2017 September 27th ER

Hospitilization for Gilenya on October 4th 2017

ER 12.01.2018

(New Jan 24th) Pictures in Tijuana, Mexico ER

Brazil

Brazil ER Report November 2017

(New Jan 24th) Pictures in Brazil ER

History Behind 2017 November 12th - Brazil San Lucas ER

Brazil ER Report Translation

Germany

ER Report Germany March 2018

(New Jan 24th) Pictures in Germany ER

Translation of ER Report Germany March 2018

History Behind 2018 March 17th Bundeswehrkrankenhaus Berlin ER

(New) Plasmapheresis for Emergency

Plasmapheresis Report 12-14th September 2018

2018 September 14th Dr. Luis Amaya Plasmapheresis

(New 11th) Pictures During Hospital Treatment

Optic Neuropathy/Eye Tests Due to MS

VEP - Optic Neuropathy - Narendra Jana

Visual Field Macula and Optic Nerve Test - Narendra Jana

VEP for Optic Neuropathy

2019.07.16 VEP Test at Apollo Hospital

Determination of Progressive MS

Dr. Hugo's Assesement of MRIs and Medication Need

Dr. Klaffke Assement of Medication Need and MS

Dr. Manjarrez's-NarendraJana

FDG PET/Dementia Documents

Early 2016 FDG Pet-Narendra Jana

(New 1st) Before and After FDG Comparison with Medication (how medication improves brain function)

Long Term FDG PET 2018

History Behind FDG PET Diagnsotic

Seizures Due to MS

March 2016 EEG Report with Waveform-Narendra Jana

May 2016 2 Day Video EEG - India - Narendra Jana

2016 April 21st Bangkok Thailand, Bumrungrad Hospital Epilepsy

2016 May 4th 2 Day EEG in Chennai, India at SIMs Hospital

Treatment with Rituximab to Try to Limit Progressive MS

Discharge Summary for Rituximab Therapy

Second Day IV Discharge Summary on January 31st 2019

(New) History Behind Rituximab Treatment

(New) Blood Tests and Drug Tests

(New) Blood Tests

0-Blood Liver Chemisty 11.08.2017

1-Blood Liver Chemisty 11.10.2017

2-Blood Liver Chemistry 9.21.2018

3-Blood Liver Chemistry 9.21.2018-2

4-Thyroid Blood Liver Chemisty 11.02.2018

(New) Drug Tests

Why? Because the US often makes the argument that the typical effects of MS could be caused by something other than MS. Its nonsensicle but as precaution I do ocassional drug tests to show otherwise. These tests span more than a decade and all with negative results.

Multiple Sclerosis and the secondary effects of seizures, dementia, ocassional immobility, and optic neuropathy are unique to MS and not replicable by any other pathology. There is no drug that could do it, only MS could.

0-Drug Test 4.22.2008-Umass Memorial

1-Drug Test 02.11.2009-Umass Memorial

2-Drug Alcohol Blood Test 04.28.2010-Umass Memorial

3-Drug Alcohol Test 04.28.2010-Umass Memorial

4-Drug Test 07.03.2013-Dr. Charles Rosenbaum

5-Drug Test 2016.04.13 Bangkok Hospital

6-Drug and STD Test 5.21.2016

7-Drug Test 9.9.2016

8-Drug Test 12.1.2016

9-Drug Test 12.14.2016

10-Drug Test 12.28.2016

11-Drug Test 4.4.2017

12-Drug Test 8.2.2017

13-Drug Test 12.8.2017

14-Drug Test 6.26.2018

15-Drug Test 10.25.2018

Video Explanation of Medical Documents:

(New 23rd) Medications and Defining a Single Cause of the Clinical Condition

(New 27th) Differential Diagnosis

(New March 12th) Defining a Single Cause of Neurodegeneration (Dr. Evan Murrays Perpetuated Medical Negligence) with Gross Evidence to Substantiate